OpGen to Present Advancements in Antibiotic Susceptibility and Whole Genome Sequencing at ASM Microbe 2017
May 25 2017 - 8:00AM
OpGen, Inc. (NASDAQ:OPGN) today announced that data on its Acuitas®
Rapid Test in development and Acuitas Whole Genome Sequence
Analysis will be presented at ASM Microbe 2017 being held June 1-5,
2017 in New Orleans, LA. These data will demonstrate the company’s
ability to predict phenotypic resistance across antibiotic classes
for Gram-negative infections using rapid genetic testing and
predictive algorithms from its Acuitas Lighthouse® Knowledgebase.
It will also showcase advances in being able to discriminate
bacterial strains using more genes to solve current limitations
with conventional strain typing methods.
The details for the poster presentations at ASM Microbe are as
follows:
Session info: 186 - AAID01 - Antibacterial
Resistance: Genomics and New Methodologies to Trace Antimicrobial
ResistancePoster title: Predicting Antibiotic
Resistance in Gram-Negative Bacilli by Rapid Detection of
Resistance Genes (#87)Presenter: Terry Walker,
Ph.D. Date and time: Saturday, June 3, 12:15
– 2:15 PM CEDT Location: Exhibit Hall D,
Exhibit and Poster Hall
Session info: 186 - AAID01 - Antibacterial
Resistance: Genomics and New Methodologies to Trace Antimicrobial
ResistancePoster title: Core Genome
Multilocus Sequence Typing Scheme for High-Resolution Typing of
Escherichia coli (#72)Presenter: Weizhong Chang,
Ph.D. Date and time: Saturday, June 3, 12:15
– 2:15 PM CEDT Location: Exhibit Hall D,
Exhibit and Poster Hall
About OpGen OpGen, Inc. is harnessing
the power of informatics and genomic analysis to provide complete
solutions for patient, hospital and network-wide infection
prevention and treatment. Learn more at www.opgen.com and
follow OpGen on Twitter and LinkedIn.
OpGen®, Acuitas®, Acuitas Lighthouse® and QuickFISH® are
registered trademarks of OpGen, Inc.
OpGen Contact:
Michael Farmer
Director, Marketing
240-813-1284
mfarmer@opgen.com
InvestorRelations@opgen.com
Investor and Media Contact:
Cammy Duong
MacDougall Biomedical Communications
781-591-3443
cduong@macbiocom.com
OpGen (NASDAQ:OPGN)
Historical Stock Chart
From Apr 2024 to May 2024
OpGen (NASDAQ:OPGN)
Historical Stock Chart
From May 2023 to May 2024